This comparative analysis is the first example of systematic evaluation of the quality of health care concerning diabetes patients in the Czech Republic. Data concerning the Czech Republic were obtained from two cross sectional studies 1,2 . Comparison was done with an adequate study from 8 new European Union countries 3 and other published studies. Regarding short term parameters of quality of diabetes patient's health care no significant differences were observed between the Czech Republic and Eastern even Western European countries. On the other hand we could be concerned with the unsatisfactory levels certain parameters such as HbA1c. Based on this pilot project it is evident that there is a need of continuous follow-up of parameters of the quality of health care of diabetes patients especially with respect of more effective evaluation of changes in the treatment algorithms. Valid parameters of the quality of the health care are essential milestones for establishment of detailed pharmacoeconomic analyses which would help for sustainable investments in the treatment of the diabetic patients in the Czech Republic.
Methods
Data were extracted from Czech cross-sectional studies from 20051 and 20072 and from European-based studies3. Follow-up of short term parameters of quality of healthcare (HbA1c, BMI, blood pressure, lipids, treatment algorithms) which help to predict long-term incidence of complications (s se ee e t ta ab bl le e 2 2). Frequency of microvascular and macrovascular complications was also assessed and the data were compared to statistics of the Czech Institute for Health Information and Statistics. T Ta ab bl le e 2 2: : Short term parameters of quality of health care:
• Diabetes compensation (level of HbA1c, reaching of end-point levels)
• Control of other risk factors (BMI, blood pressure, level of lipids) • Treatment algorithms Long term parameters of quality of healthcare:
• Occurrence of microvascular complications (diabetic nephropathy, neuropathy, and retinopathy) • Occurrence of macrovascular complications (coronary heart disease, peripheral arterial disease, and stroke)
Objectives
Aim of this study was to evaluate the quality of medical treatment of diabetes patients and its trends in the Czech Republic and to compare the findings with the international research. Based on the International Diabetes Federation the prevalence of diabetes was 9,7% in 2007 and is expected to rise to 11,7% in 2025 in the Czech Republic (s se ee e t ta ab bl le e 1 1).
91.6% of patients from respected number of patient (approx. 774 000 patients) are type 2 diabetes patients. Such condition is considered preventable therefore this analysis doesn't focus only on the quality of compensation of the level of blood glucose but also on broader perspective including the complex modification of risks of diabetes 2 type patients.
Results
C Co on nc ce er rn ni in ng g s sh ho or rt t--t te er rm m p pa ar ra am me et te er rs s t th he er re e i is s w wi id de e v va ar ri ia at ti io on n a ac cr ro os ss s E Eu ur ro op pe ea an n c co ou un nt tr ri ie es s. . W We e h ha av ve e n no ot t f fo ou un nd d s si ig gn ni if fi ic ca an nt t d di if ff fe er re en nc ce es s b be et tw we ee en n C CR R a an nd d s se el le ec ct te ed d E Eu ur ro op pe ea an n c co ou un nt tr ri ie es s 3 3 a al lt th ho ou ug gh h t th he er re e i is s i in ns su uf ff fi ic ci ie en nt t e ev vi id de en nc ce e i in n r re ev ve ea al li in ng g e en nd d--p po oi in nt t v va al lu ue es s, , e e. .g g. . H Hb bA A1 1c c ( (7 7, ,7 7 % % i in n C CR R v vs s. . 7 7, ,8 8 % % i in n G Gr re ea at t B Br ri it ta ai in n 4 4 ) ), , B BM MI I ( (2 29 9, ,9 9 i in n C CR R2 2 v vs s. . 2 28 8, ,7 7 C CO OD DE E--2 2 s st tu ud dy y 5 5 ) ) a an nd d r re ea ac ch hi in ng g o of f t ta ar rg ge et t H Hb bA A1 1c c v va al lu ue es s ( (3 36 6--4 42 2% % 1 1, ,2 2 i in n C CR R v vs s. . 3 36 6% % 3 3 ) ) ( (s se ee e T Ta ab bl le e 2 2) ). .
T Th he e d di ia ab be et ti ic c p pa at ti ie en nt ts s a ar re e r re ea ac ch hi in ng g t th he e t ta ar rg ge et t t th he er ra ap pe eu ut ti ic c v va al lu ue es s o on nl ly y i in n m mi in no or ri it ty y o of f c ca as se es s ( (3 31 1% % i in n s sy ys st to ol li ic c b bl lo oo od d p pr re es ss su ur re e 1 1 , , 2 27 7% % i in n t to ot ta al l c ch ho ol le es st te er ro ol l1 1 a an nd d i in n 3 36 6% % o of f H Hb bA A1 1c c 2 2 ) ) ( (s se ee e t ta ab bl le es s 2 2 a an nd d 3 3) ). .
T Th he e m ma ai in n d di if ff fe er re en nc ce es s a an nd d s si im mi il la ar ri it ti ie es s b be et tw we ee en n t tr re ea at tm me en nt t i in n t th he e C Cz ze ec ch h R Re ep pu ub bl li ic c a an nd d o ot th he er r c co ou un nt tr ri ie es s a ar re e d de es sc cr ri ib be ed d i in n t ta ab bl le es s 4 4 a an nd d 5 5. . 7 74 4 % % o of f C Cz ze ec ch h p pa at ti ie en nt ts s c co om mp pa ar re ed d w wi it th h 5 50 0 % % E Eu ur ro op pe ea an n p pa at ti ie en nt ts s a ar re e t tr re ea at te ed d w wi it th h m me et tf fo or rm mi in n. . P Pe er rc ce en nt ta ag ge e o of f p pa at ti ie en nt ts s u us si in ng g a an nt ti ih hy yp pe er rt te en nt ti io on n d dr ru ug gs s ( (8 83 3 % % 7 7 ) ) a an nd d h hy yp po ol li ip pi id de em mi ic cs s ( (6 63 3 % % 7 7 ) ) i is s s si im mi il la ar r i in n t th he e C Cz ze ec ch h R Re ep pu ub bl li ic c a an nd d t th he e E Eu ur ro op pe ea an n a av ve er ra ag ge e 3 3 . . T Th he es se e f fi ig gu ur re es s r re ef fl le ec ct t t th he e p pr re ev va al le en nc ce e o of f a as ss so oc ci ia at te ed d d di is se ea as se es s. . L Lo on ng g t te er rm m p pa ar ra am me et te er rs s o of fu ua al li it ty y o of f h he ea al lt th hc ca ar re e: : T Th he er re e i is s h hi ig gh h p pr re ev va al le en nc ce e o of f d di ia ab be et ti ic c m ma ac cr ro ov va as sc cu ul la ar r a an nd d m mi ic cr ro ov va as sc cu ul la ar r c co om mp pl li ic ca at ti io on ns s --d di ia ab be et ti ic c n ne ep ph hr ro op pa at th hy y = = 2 28 8, ,3 3% % 7 7 , , r re et ti in no op pa at th hy y = = 2 25 5% % 7 7 , , d di ia ab be et ti ic c f fo oo ot t = = 4 4, ,6 6% % 7 7 ( (s se ee e t ta ab bl le e 6 6) ). . D Da at ta a o ob bt ta ai in ne ed d f fr ro om m t th he e I In ns st ti it tu ut te e o of f H He ea al lt th h I In nf fo or rm ma at ti io on n a an nd d S St ta at ti is st ti ic cs s 6 6 a ar re e c co ol ll le ec ct te ed d o on n r re eg gu ul la ar r b ba as si is s. . U Un nf fo or rt tu un na at te el ly y d da at ta a a ar re e n no ot t c co ol ll le ec ct te ed d a as s a an n a ac ct ti iv ve e c cl li in ni ic ca al l s se ea ar rc ch h b bu ut t o on nl ly y a as s b ba as se ed d o on n a an n o ob bl li ig ga at to or ry y p pa as ss si iv ve e r re ep po or rt ti in ng g s sy ys st te em m t th he er re ef fo or re e d da at ta a o on n o oc cc cu ur rr re en nc ce e o of f m mi ic cr ro ov va as sc cu ul la ar r c co om mp pl li ic ca at ti io on ns s c ca an n b be e u un nd de er re es st ti im ma at te ed d. . M Ma ac cr ro ov va as sc cu ul la ar r c co om mp pl li ic ca at ti io on ns s a ar re e d de es sc cr ri ib be ed d i in n t ta ab bl le e 7 7, , t th he e p pr re ev va al le en nc ce e o of f c co or ro on na ar ry y h he ea ar rt t d di is se ea as se e ( (C CH HD D) ) w wa as s o ob bs se er rv ve ed d t to o b be e b be et tw we ee en n 4 42 2% % 1 1 a an nd d 4 49 9% % 7 7 , , s st tr ro ok ke e b be et tw we ee en n 9 9, ,3 3% % 7 7 a an nd d 1 11 1. .4 4% % 1 1 . . T Th he er re e i is s n no o s si ig gn ni if fi ic ca an nt t d di if ff fe er re en nc ce e b be et tw we ee en n t th he e C Cz ze ec ch h d da at ta a 1 1, ,7 7 a an nd d t th he e E EU U c co ou un nt tr ri ie es s 3 3 n ne ev ve er rt th he el le es ss s t th he er re e i is s a a s sp pa ac ce e f fo or r i im mp pr ro ov ve em me en nt t i in n t te er rm ms s o of f e ea ar rl ly y d de et te ec ct ti io on ns s o of f t th he es se e c co om mp pl li ic ca at ti io on ns s. . 
